corporary

RAYNER

Active
SIREN 905210977 VAT number FR88905210977

Business purpose.

La distribution de produits, principalement des lentilles Intraoculaires et des injecteurs, fournis et fabriqués par sa société mère ; la distribution d'une gamme de produits pharmaceutiques fabriquée par sa société mère et certains produits fabriqués par des tiers avec le consentement et l'approbation de sa société mère.

Identity

Legal form
SAS, simplified joint-stock company
Activity
Wholesale (intercompany trade) of pharmaceutical goods (46.46Z)
Sector
Wholesale trade, except of motor vehicles and motorcycles
Headcount
10 to 19 employees
Created
2 Nov 2021
Share capital
10,000.00 EUR
Financial year end
31/12
Establishments
4

Directors

Related companies

Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.

  • CLUNY via DAVID GEOFFREY ALLAN

Other companies at the same address

2 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

39 / 100 D

Confidence: high · computed on the financial year ended 31 Dec 2025

Equity to assets (-82.2 %)
0.0 out of 30
EBITDA margin (8.6 %)
13.9 out of 25
Liquidity (36.9 %)
0.5 out of 20
Debt (0.0 %)
15.0 out of 15
Revenue trend (39.9 %)
10.0 out of 10

formula fin-1.0

Legal score

90 / 100 A

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
20.0 out of 20
Age (5.0 years)
10.1 out of 20
Accounts filed recently
20.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Revenue and net income by financial year
2023 2024 2025

Revenue Net income

Financial year Revenue Change EBITDA Net income
31 Dec 2025 3,084,582 € +39.9 % 264,596 € 199,664 €
31 Dec 2024 2,204,110 € +208.3 % 42,485 € -79,152 €
31 Dec 2023 715,032 € first year on record -1,463,072 € -1,470,042 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Collective agreements

Agreements declared by the employer in its payroll filings.

  • Convention collective nationale de la fabrication et du commerce des produits à usage pharmaceutique, parapharmaceutique et vétérinaire du 1er juin 1989. Etendue par arrêté du 20 avril 1990 JORF 29 avril 1990

    IDCC 1555 · repealed · 1 establishment · declared in July 2026

Legal notices

  • Filing of accounts 12 Jul 2026
    Court :
    Greffe du Tribunal des Activités Economiques de nanterre
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2025

    BODACC C n 20260131, annonce n 12052 · Proof of publication (PDF)

  • Filing of accounts 29 Jul 2025
    Court :
    Greffe du Tribunal des Activités Economiques de nanterre
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2024

    BODACC C n 20250143, annonce n 30685 · Proof of publication (PDF)

  • Filing of accounts 29 Nov 2024
    Court :
    Greffe du Tribunal de Commerce de lille métropole
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2023

    BODACC C n 20240231, annonce n 2425 · Proof of publication (PDF)

  • Registration 29 Aug 2024
    Court :
    Greffe du Tribunal de Commerce de Nanterre
    Filing :
    immatriculation suite à transfert de son siège social hors ressort.

    BODACC A n 20240167, annonce n 1160 · Proof of publication (PDF)

  • Filing of accounts 26 Mar 2024
    Court :
    Greffe du Tribunal de Commerce de lille métropole
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2022

    BODACC C n 20240060, annonce n 3218 · Proof of publication (PDF)

  • Amendment 13 Jun 2023
    Court :
    Greffe du Tribunal de Commerce de Lille Métropole
    Amendment :
    modification survenue sur l'administration

    BODACC B n 20230112, annonce n 2611 · Proof of publication (PDF)

  • Amendment 11 Sep 2022
    Court :
    Greffe du Tribunal de Commerce de Lille Métropole
    Amendment :
    modification survenue sur l'adresse du siège, l'adresse de l'établissement et la date de début d'activité

    BODACC B n 20220176, annonce n 879 · Proof of publication (PDF)

  • Amendment 22 Mar 2022
    Court :
    Greffe du Tribunal de Commerce de Lille Métropole
    Amendment :
    modification survenue sur la dénomination, l'adresse du siège, l'adresse de l'établissement et la date de début d'activité

    BODACC B n 20220057, annonce n 1800 · Proof of publication (PDF)

  • Incorporation 25 Nov 2021
    Court :
    Greffe du Tribunal de Commerce de Lille Métropole

    BODACC A n 20210229, annonce n 1206 · Proof of publication (PDF)

Annual accounts as PDF →

Filings and accounts

  • Formality 17 Apr 2024

Change history

  • officer_appointed (empty) → Directeur general 9 Oct 2026
  • officer_appointed (empty) → President de SAS 9 Oct 2026
  • registered_address 395 rue du General de Gaulle 59700 Marcq-en-Baroeul → 393 rue du General de Gaulle 59700 Marcq-en-Baroeul 3 Oct 2026
  • registered_address (empty) → 395 rue du General de Gaulle 59700 Marcq-en-Baroeul 1 Oct 2026
  • capital (empty) → 10000.00 1 Oct 2026

Frequently asked questions about RAYNER

What is the SIREN number of RAYNER?
The SIREN number of RAYNER is 905210977. Its intra-community VAT number is FR88905210977.
Where is the head office of RAYNER?
Head office address: 13 RUE TRANSVERSALE, 92230 GENNEVILLIERS.
When was RAYNER founded?
RAYNER was founded on 2 Nov 2021.
What does RAYNER do?
Its declared main activity is: Wholesale (intercompany trade) of pharmaceutical goods (NAF code 46.46Z).
Who runs RAYNER?
The officers listed in the register are DAVID GEOFFREY ALLAN (Directeur general), JAMES ANDREW CRUTCHLOW (President de SAS).
What is the revenue of RAYNER?
The latest published revenue is 3,084,582 €, for the 2025 financial year.
How many employees does RAYNER have?
The declared headcount is 10 to 19 employees. Insee data for 2024.
Is RAYNER subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Show this profile on your website →

Report an error or request removal of this data